ADAM9 and chronic obstructive pulmonary disease: The metalloprotease ADAM9 has been recently recognized as an important mediator of not only acute lung injury, but also COPD, being implicated in lung inflammation, alveolar septal apoptosis, emphysema, small airway fibrosis, and mucous cell metaplasia in mice [19, 20].